Mr Virginnio Proost
Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
The eligibility of patients with an inherited cardiac disease for therapy with a subcutaneous implantable cardioverter-defibrillator.
Event: ESC Congress 2022
Topic: Device Treatment
Session: Device treatment of arrhythmias
ESC 365 is supported by
